Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Arsenic trioxide induces apoptosis preferentially in B-CLL cells of patients with unfavourable prognostic factors including del17p13.

Merkel O, Heyder C, Asslaber D, Hamacher F, Tinhofer I, Holler C, Stöcher M, Prokesch A, Papak C, Scheideler M, Trajanoski Z, Greil R.

J Mol Med (Berl). 2008 May;86(5):541-52. doi: 10.1007/s00109-008-0314-6. Epub 2008 Feb 23.

PMID:
18297255
2.

Matrix metalloproteinase-9 is involved in chronic lymphocytic leukemia cell response to fludarabine and arsenic trioxide.

Amigo-Jiménez I, Bailón E, Ugarte-Berzal E, Aguilera-Montilla N, García-Marco JA, García-Pardo A.

PLoS One. 2014 Jun 23;9(6):e99993. doi: 10.1371/journal.pone.0099993. eCollection 2014.

3.

Role of GSTP1-1 in mediating the effect of As2O3 in the Acute Promyelocytic Leukemia cell line NB4.

Bernardini S, Nuccetelli M, Noguera NI, Bellincampi L, Lunghi P, Bonati A, Mann K, Miller WH Jr, Federici G, Lo Coco F.

Ann Hematol. 2006 Oct;85(10):681-7. Epub 2006 May 30.

PMID:
16733740
4.

The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms.

Zhang W, Ohnishi K, Shigeno K, Fujisawa S, Naito K, Nakamura S, Takeshita K, Takeshita A, Ohno R.

Leukemia. 1998 Sep;12(9):1383-91.

PMID:
9737686
5.

Arsenic trioxide induces apoptosis in B-cell chronic lymphocytic leukemic cells through down-regulation of survivin via the p53-dependent signaling pathway.

Zhang XH, Feng R, Lv M, Jiang Q, Zhu HH, Qing YZ, Bao JL, Huang XJ, Zheng XL.

Leuk Res. 2013 Dec;37(12):1719-25. doi: 10.1016/j.leukres.2013.09.019. Epub 2013 Sep 29.

6.

Arsenic trioxide induces apoptosis through a reactive oxygen species-dependent pathway and loss of mitochondrial membrane potential in HeLa cells.

Woo SH, Park IC, Park MJ, Lee HC, Lee SJ, Chun YJ, Lee SH, Hong SI, Rhee CH.

Int J Oncol. 2002 Jul;21(1):57-63.

PMID:
12063550
7.

Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.

Maeda H, Hori S, Nishitoh H, Ichijo H, Ogawa O, Kakehi Y, Kakizuka A.

Cancer Res. 2001 Jul 15;61(14):5432-40.

8.

Arsenic trioxide induces apoptosis in HTLV-I infected T-cell lines and fresh adult T-cell leukemia cells through CD95 or tumor necrosis factor alpha receptor independent caspase activation.

Ishitsuka K, Ikeda R, Utsunomiya A, Uozumi K, Hanada S, Suzuki S, Takeuchi S, Takatsuka Y, Takeshita T, Ohno N, Arima T.

Leuk Lymphoma. 2002 May;43(5):1107-14.

PMID:
12148893
9.

Adaphostin-induced apoptosis in CLL B cells is associated with induction of oxidative stress and exhibits synergy with fludarabine.

Shanafelt TD, Lee YK, Bone ND, Strege AK, Narayanan VL, Sausville EA, Geyer SM, Kaufmann SH, Kay NE.

Blood. 2005 Mar 1;105(5):2099-106. Epub 2004 Sep 23.

10.

Arsenic trioxide and bortezomib interact synergistically to induce apoptosis in chronic myelogenous leukemia cells resistant to imatinib mesylate through Bcr/Abl‑dependent mechanisms.

Xu W, Wei W, Yu Q, Wu C, Ye C, Wu Y, Yan H.

Mol Med Rep. 2014 Sep;10(3):1519-24. doi: 10.3892/mmr.2014.2333. Epub 2014 Jun 16.

PMID:
24939418
11.

Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53.

Byrd JC, Shinn C, Waselenko JK, Fuchs EJ, Lehman TA, Nguyen PL, Flinn IW, Diehl LF, Sausville E, Grever MR.

Blood. 1998 Nov 15;92(10):3804-16.

12.

17p Deletion is associated with resistance of B-cell chronic lymphocytic leukemia cells to in vitro fludarabine-induced apoptosis.

Turgut B, Vural O, Pala FS, Pamuk GE, Tabakcioğlu K, Demir M, Ongören S, Soysal T, Algüneş C.

Leuk Lymphoma. 2007 Feb;48(2):311-20.

PMID:
17325891
13.

Carbonyl reductase 1 offers a novel therapeutic target to enhance leukemia treatment by arsenic trioxide.

Jang M, Kim Y, Won H, Lim S, K R J, Dashdorj A, Min YH, Kim SY, Shokat KM, Ha J, Kim SS.

Cancer Res. 2012 Aug 15;72(16):4214-24. Epub 2012 Jun 19.

14.

Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice.

Kinjo K, Kizaki M, Muto A, Fukuchi Y, Umezawa A, Yamato K, Nishihara T, Hata J, Ito M, Ueyama Y, Ikeda Y.

Leukemia. 2000 Mar;14(3):431-8.

PMID:
10720138
15.
16.

Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide.

Hour TC, Huang CY, Lin CC, Chen J, Guan JY, Lee JM, Pu YS.

Anticancer Drugs. 2004 Sep;15(8):779-85.

PMID:
15494640
17.

Resveratrol synergistically triggers apoptotic cell death with arsenic trioxide via oxidative stress in human lung adenocarcinoma A549 cells.

Gu S, Chen C, Jiang X, Zhang Z.

Biol Trace Elem Res. 2015 Feb;163(1-2):112-23. doi: 10.1007/s12011-014-0186-2. Epub 2014 Nov 29.

PMID:
25431299
18.
19.

Arsenic trioxide inhibits cell growth in SH-SY5Y and SK-N-AS neuroblastoma cell lines by a different mechanism.

Woo SY, Lee MY, Jung YJ, Yoo ES, Seoh JY, Shin HY, Ahn HS, Ryu KH.

Pediatr Hematol Oncol. 2006 Apr-May;23(3):231-43.

PMID:
16517539
20.

Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis.

Kitamura K, Minami Y, Yamamoto K, Akao Y, Kiyoi H, Saito H, Naoe T.

Leukemia. 2000 Oct;14(10):1743-50.

PMID:
11021749

Supplemental Content

Support Center